Enlivex Therapeutics Ltd
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel. Show More...
-
Website https://www.enlivex.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.82 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.84 -4.31 -22.8 -43.2 -40.13 -7.52 -11.2 -8.88 -8.21 Dividends USD Payout Ratio % * Shares Mil 1.0 3.0 Book Value Per Share * EUR 56.88 26.25 7.51 6.58 1.19 2.13 Free Cash Flow Per Share * EUR -28.56 -39.84 -17.83 -13.42 -7.1 Return on Assets % -146.79 -40.09 -36.35 -57.47 -102.88 -83.43 -66.88 -67.02 -27.2 Financial Leverage (Average) 2.11 1.02 1.07 1.14 1.22 1.15 1.2 1.56 1.17 Return on Equity % -309.46 -41.61 -38.76 -63.22 -120.33 -100.24 -79.41 -93.65 -33.88 Return on Invested Capital % -309.46 -41.53 -39.23 -63.79 -120.83 -100.74 -81.64 -94.83 -39.33 Interest Coverage -571.5 Current Ratio 1.93 43.35 14.42 8.11 5.46 7.87 9.09 2.74 6.86 Quick Ratio 1.93 43.35 4.68 2.96 3.59 7.73 8.84 2.41 6.23 Debt/Equity